News | September 21, 2023
Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
Mpower an initiative of Aditya Birla Education Trust works in the space of Mental health
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Meningitis still affects more than 2.5 million people globally each year
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Subscribe To Our Newsletter & Stay Updated
